MAPT and Alzheimer disease: Additionally, the dysregulation of ubiquitin-mediated pathways is associated with alterations in learning and memory ability, Aβ plaque formation, hyperphosphorylation of tau protein, as well as synaptic plasticity and immune function changes in AD mouse models19,20, 21.